Steris (STE) EBT Growth (3y) (2021 - 2026)
Analysis
Steris (STE) EBT Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.43 Bn | 177.83 Bn | 7.27 Bn | -2.34% |
| 2 | Intuitive Surgical | 124.55 Bn | 119.33 Bn | 1.96 Bn | 28.31% |
| 3 | Medtronic | 117.91 Bn | 109.10 Bn | 6.34 Bn | 13.94% |
| 4 | Stryker | 105.51 Bn | 102.03 Bn | 4.50 Bn | 20.27% |
| 5 | Boston Scientific | 66.23 Bn | 65.69 Bn | 3.85 Bn | 35.51% |
| 6 | Edwards Lifesciences | 49.46 Bn | 45.21 Bn | 1.35 Bn | 23.63% |
| 7 | Alcon | 33.87 Bn | 32.41 Bn | 1.68 Bn | -30.37% |
| 8 | Dexcom | 32.08 Bn | 30.13 Bn | 830.00 Mn | 25.85% |
| 9 | Steris | 21.05 Bn | 20.56 Bn | 684.20 Mn | 17.92% |
| 10 | Zimmer Biomet Holdings | 18.27 Bn | 17.86 Bn | 1.54 Bn | -2.68% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.92% |
| Mar 31, 2026 | 14.40% |
| Dec 31, 2025 | 14.54% |
| Sep 30, 2025 | 16.68% |
| Jun 30, 2025 | 16.68% |
| Mar 31, 2025 | 16.82% |
| Dec 31, 2024 | 7.83% |
| Sep 30, 2024 | 29.57% |
| Jun 30, 2024 | 100.38% |
| Mar 31, 2024 | 11.98% |
| Dec 31, 2023 | 10.79% |
| Sep 30, 2023 | 5.22% |
| Jun 30, 2023 | 15.37% |
| Mar 31, 2023 | 11.16% |
| Dec 31, 2022 | 8.59% |
| Sep 30, 2022 | 10.74% |
| Jun 30, 2022 | 13.67% |
| Mar 31, 2022 | -2.36% |
| Dec 31, 2021 | 46.71% |
| Sep 30, 2021 | -2.02% |